What changed in Encompass Health Corporation's latest annual report
In the year ended 31 Dec 2025, Encompass Health Corporation's revenue rose 10.5% to USD 5.94bn, from USD 5.37bn; net income rose 24.2% to USD 566.20m, from USD 455.70m; shareholders' equity rose 18% to USD 2.44bn, from USD 2.07bn.
Year ended 31 Dec 2025. Source: 10-K filed 26 Feb 2026, read it on SEC EDGAR.
USD 5.37bn to USD 5.94bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 5.37bn | 5.94bn | Up 10.5% |
| Net income | 455.70m | 566.20m | Up 24.2% |
| Total assets | 6.53bn | 7.09bn | Up 8.5% |
| Total liabilities | 3.69bn | 3.81bn | Up 3.5% |
| Cash and cash equivalents | 85.40m | 72.20m | Down 15.5% |
| Shareholders' equity | 2.07bn | 2.44bn | Up 18% |
Questions people ask
Did Encompass Health Corporation's revenue grow last year?
Revenue grew 10.5%, from USD 5.37bn to USD 5.94bn in the year ended 31 Dec 2025.
Is Encompass Health Corporation profitable?
Yes. Net income was USD 566.20m in the year ended 31 Dec 2025. The year before: USD 455.70m.
How much cash and debt does Encompass Health Corporation have?
At its latest year end (31 Dec 2025), Encompass Health Corporation reported cash and cash equivalents of USD 72.20m.
Where do these numbers come from?
From Encompass Health Corporation's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Encompass Health Corporation?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demo